Meghmani Organics Limited — Investor Meet, 12-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

**Financial Performance:** Meghmani Organics has demonstrated robust financial recovery in Q3 FY25, with revenues soaring 62% year-over-year to ₹558 crore. EBITDA rebounded significantly to ₹60.4 crore from a prior year loss of ₹0.4 crore, while PAT transitioned to a profit of ₹30.2 crore from a loss of ₹27.2 crore. The Crop Protection segment contributed 74% of total revenues, reflecting a 72% year-on-year increase, while the Pigment segment grew by 40%.

**Future Outlook and Growth Drivers:** Management highlighted sustained demand recovery, particularly in Agrochemicals, due to reduced inventory levels. They project EBITDA margins will stabilize between 14% to 16% moving forward, with Crop Nutrition initiatives gaining traction through partnerships and demonstrations.

**Order Book and Operational Updates:** The Crop Protection segment's production increased by 12% to 10,700 metric tons, with capacity utilization at 78%. The Pigment segment produced 3,900 metric tons, operating at 48% capacity, indicating potential for future growth. The Titanium Dioxide segment is facing pricing pressures due to aggressive dumping from China, but management anticipates the introduction of antidumping duties will support pricing recovery.

**Analyst Q&A Insights:** Analysts raised concerns on margin sustainability and competitive pressures, especially regarding Chinese imports. Management responded optimistic about maintaining demand and revenue run rates while acknowledging challenges posed by fluctuating raw material costs.

**Market or Regulatory Updates:** The impending antidumping duties on Titanium Dioxide imports from China, expected by March, are anticipated to positively impact pricing and utilization rates.

**Strategic Focus Areas:** Management is focusing on leveraging technological advancements in product offerings, particularly in the Crop Protection segment, alongside a cautious approach to capital allocation given the mixed performance in the Pigment division.

**Investor Insight:** The financial recovery, coupled with a strong market position in core segments and strategic initiatives, suggests a favorable outlook for the company. This positions it towards a decidedly optimistic stance for investors, indicating a preference for holding shares as the business gains momentum.